Key result
Altering protease restriction sequences within the FMDV P1 polyprotein enabled successful processing and production of FMDV capsid proteins by the TEV protease in mammalian and bacterial cells.
Modifying FMDV P1 polyprotein to be processed by TEVpro enables successful production of FMDV capsid proteins, potentially overcoming host cell toxicity associated with wild-type 3Cpro in vaccine production.
Enables TEV-based FMDV capsid production in cells; leaves open scalability for vaccine platforms.
Protective immunity to viral pathogens often includes production of neutralizing antibodies to virus capsid proteins. Many viruses produce capsid proteins by expressing a precursor polyprotein and related protease from a single open reading frame. The foot-and-mouth disease virus (FMDV) expresses a 3C protease (3Cpro) that cleaves a P1 polyprotein intermediate into individual capsid proteins, but the FMDV 3Cpro also degrades many host cell proteins and reduces the viability of host cells, including subunit vaccine production cells. To overcome the limitations of using the a wild-type 3Cpro in FMDV subunit vaccine expression systems, we altered the protease restriction sequences within a FMDV P1 polyprotein to enable production of FMDV capsid proteins by the Tobacco Etch Virus NIa protease (TEVpro). Separate TEVpro and modified FMDV P1 proteins were produced from a single open reading frame by an intervening FMDV 2A sequence. The modified FMDV P1 polyprotein was successfully processed by the TEVpro in both mammalian and bacterial cells. More broadly, this method of polyprotein production and processing may be adapted to other recombinant expression systems, especially plant-based expression.
No takes yet. Share an insight, caveat, or question.
Puckette et al. (2018) studied Foot-and-mouth disease virus (FMDV) subunit vaccine production. Tobacco Etch Virus NIa protease (TEVpro) was evaluated on Processing of modified FMDV P1 polyprotein into capsid proteins. Altering protease restriction sequences within the FMDV P1 polyprotein enabled successful processing and production of FMDV capsid proteins by the TEV protease in mammalian and bacterial cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: